(Q83468020)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

review article

1 reference

title

Graft-versus-host disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

James L M Ferrara

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Pavan Reddy

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Ernst Holler

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

English

0 references

publication date

11 March 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

number of pages

12

1 reference

inferred from page(s)

published in

The Lancet

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

373

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

9674

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

1550-1561

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

Haematopoietic cell transplantation as immunotherapy

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Immunobiology of allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

T-lymphocyte-antigen interactions in transplant rejection

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

HLA Association with hematopoietic stem cell transplantation outcome: the number of mismatches at HLA-A, -B, -C, -DRB1, or -DQB1 is strongly associated with overall survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Umbilical cord blood transplantation in adults: results of the prospective Cord Blood Transplantation (COBLT)

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Umbilical-cord blood transplantation for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Molecules and mechanisms of the graft-versus-leukaemia effect

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Mismatches of minor histocompatibility antigens between HLA-identical donors and recipients and the development of graft-versus-host disease after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Relation of an Interleukin-10 Promoter Polymorphism to Graft-versus-Host Disease and Survival after Hematopoietic-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Non-HLA immunogenetics in hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Successful adoptive transfer and in vivo expansion of human haploidentical NK cells in patients with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

NK cells: a lesson from mismatched hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Prognostic significance of NOD2/CARD15 variants in HLA-identical sibling hematopoietic stem cell transplantation: effect on long-term outcome is confirmed in 2 independent cohorts and may be modulated by the type of gastrointestinal decontamination

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Chronic Graft-versus-Host Disease--implementation of the National Institutes of Health Consensus Criteria for Clinical Trials

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Pathogenesis and treatment of graft-versus-host disease after bone marrow transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Acute graft-vs-host disease: pathobiology and management

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Acute bleeding after allogeneic bone marrow transplantation: association with graft versus host disease and effect on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Endoscopic and histologic diagnosis of intestinal graft-versus-host disease after marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Hepatic Graft Versus Host Disease: A Study of the Predictive Value of Liver Biopsy in Diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Hepatic graft-versus-host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Prospective evaluation of 2 acute graft-versus-host (GVHD) grading systems: a joint Société Française de Greffe de Moëlle et Thérapie Cellulaire (SFGM-TC), Dana Farber Cancer Institute (DFCI), and International Bone Marrow Transplant Registry (IBMTR

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Severity of chronic graft-versus-host disease: association with treatment-related mortality and relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

The danger model: a renewed sense of self

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Prevention of graft versus host disease by inactivation of host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Acute graft-versus-host disease does not require alloantigen expression on host epithelium

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

A crucial role for antigen-presenting cells and alloantigen expression in graft-versus-leukemia responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Marrow grafts between canine siblings matched by serotyping and mixed leukocyte culture

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Peyer's patch is the essential site in initiating murine acute and lethal graft-versus-host reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Acute and chronic graft-versus-host disease after ablative and nonmyeloablative conditioning for allogeneic hematopoietic transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Host dendritic cells alone are sufficient to initiate acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Regulatory dendritic cells protect mice from murine acute graft-versus-host disease and leukemia relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Decoding the patterns of self and nonself by the innate immune system

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Pathogen recognition and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Role of adhesion molecules in activation signaling in T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Features of T cells causing H-2-restricted lethal graft-vs.-host disease across minor histocompatibility barriers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

The role of CD4+CD25hi regulatory T cells in the physiopathogeny of graft-versus-host disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Protective conditioning for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Inhibition of CD4+CD25+ regulatory T-cell function by calcineurin-dependent interleukin-2 production

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Donor-derived interferon gamma is required for inhibition of acute graft-versus-host disease by interleukin 12.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Pathophysiology of graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Interleukin-18 regulates acute graft-versus-host disease by enhancing Fas-mediated donor T cell apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

TGF- in allogeneic stem cell transplantation: friend or foe?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Cytolytic pathways in haematopoietic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Leukocyte migration and graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Absence of beta7 integrin results in less graft-versus-host disease because of decreased homing of alloreactive T cells to intestine

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Toll-like receptor control of the adaptive immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

The p55 TNF-alpha receptor plays a critical role in T cell alloreactivity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft-vs.-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Allogeneic transplantation of CD34+ selected hematopoietic cells--clinical problems and current challenges

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Effect of graft-versus-host disease prophylaxis on 3-year disease-free survival in recipients of unrelated donor bone marrow (T-cell Depletion Trial): a multi-centre, randomised phase II-III trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Antithymocyte globulin for graft-versus-host disease prophylaxis in transplants from unrelated donors: 2 randomized studies from Gruppo Italiano Trapianti Midollo Osseo (GITMO).

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Long-term follow-up of myeloablative allogeneic stem cell transplantation using Campath "in the bag" as T-cell depletion: the Leiden experience

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Partial CD8+ T-cell depletion of allogeneic peripheral blood stem cell transplantation is insufficient to prevent graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Results of alemtuzumab-based reduced-intensity allogeneic transplantation for chronic lymphocytic leukemia: a British Society of Blood and Marrow Transplantation Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

In vivo T cell depletion with pretransplant anti-thymocyte globulin reduces graft-versus-host disease without increasing relapse in good risk myeloid leukemia patients after stem cell transplantation from matched related donors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Polyclonal anti-T-cell globulin as part of the preparative regimen for pediatric allogeneic stem-cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Thymoglobulin prevents chronic graft-versus-host disease, chronic lung dysfunction, and late transplant-related mortality: long-term follow-up of a randomized trial in patients undergoing unrelated donor transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Thrombotic microangiopathy in transplantation and malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Tacrolimus-associated posterior reversible encephalopathy syndrome after allogeneic haematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Kinetics of engraftment in patients with hematologic malignancies given allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Extending postgrafting cyclosporine decreases the risk of severe graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Sirolimus and tacrolimus without methotrexate as graft-versus-host disease prophylaxis after matched related donor peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Sirolimus, tacrolimus, and low-dose methotrexate as graft-versus-host disease prophylaxis in related and unrelated donor reduced-intensity conditioning allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Sirolimus and thrombotic microangiopathy after allogeneic hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Lowered-intensity preparative regimen for allogeneic stem cell transplantation delays acute graft-versus-host disease but does not improve outcome for advanced hematologic malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Retrospective comparison of reduced-intensity conditioning and conventional high-dose conditioning for allogeneic hematopoietic stem cell transplantation using HLA-identical sibling donors in myelodysplastic syndromes.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Early antithymocyte globulin therapy improves survival in patients with steroid-resistant acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

A randomized trial comparing prednisone with antithymocyte globulin/prednisone as an initial systemic therapy for moderately severe acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Poor outcome in steroid-refractory graft-versus-host disease with antithymocyte globulin treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Photopheresis for the prevention of rejection in cardiac transplantation. Photopheresis Transplantation Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Extracorporeal photopheresis reverses experimental graft-versus-host disease through regulatory T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Immunobiology of acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Etanercept plus methylprednisolone as initial therapy for acute graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Extracorporeal photopheresis for acute and chronic graft-versus-host disease: does it work?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Inhaled corticosteroids stabilize constrictive bronchiolitis after hematopoietic stem cell transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Living-donor lobar lung transplantation for bronchiolitis obliterans after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Detection of Aspergillus galactomannan by enzyme immunoabsorbent assay in recipients of allogeneic hematopoietic stem cell transplantation: a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Long-term acyclovir for prevention of varicella zoster virus disease after allogeneic hematopoietic cell transplantation--a randomized double-blind placebo-controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

The benefit of influenza vaccination after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Use of Oseltamivir to control influenza complications after bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Current usage of intravenous immune globulin and the rationale behind it: the Massachusetts General Hospital data and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Intravenous immunoglobulin: striving for appropriate use.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Vaccination of stem cell transplant recipients: recommendations of the Infectious Diseases Working Party of the EBMT

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Bisphosphonate therapy for reduced bone mineral density in children with chronic graft-versus-host disease

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2960237-3

7 January 2021

Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors

1 reference

12 December 2020

A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment

1 reference

12 December 2020

Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences

1 reference

12 December 2020

Clonable T lymphocytes in T cell-depleted bone marrow transplants correlate with development of graft-v-host disease.

1 reference

12 December 2020

The effect of intensified extracorporeal photochemotherapy on long-term survival in patients with severe acute graft-versus-host disease

1 reference

12 December 2020

Recipient tumor necrosis factor-alpha and interleukin-10 gene polymorphisms associate with early mortality and acute graft-versus-host disease severity in HLA-matched sibling bone marrow transplants

1 reference

12 December 2020

The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation

1 reference

12 December 2020

Chronic graft versus host disease is associated with long-term risk for pneumococcal infections in recipients of bone marrow transplants.

1 reference

12 December 2020

T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities

1 reference

12 December 2020

Treatment of steroid-resistant acute graft-versus-host disease with rabbit antithymocyte globulin

1 reference

12 December 2020

Phase 3 study comparing methotrexate and tacrolimus with methotrexate and cyclosporine for prophylaxis of acute graft-versus-host disease after marrow transplantation from unrelated donors

1 reference

12 December 2020

Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Successful lung transplantation for bronchiolitis obliterans after allogeneic marrow transplantation

1 reference

12 December 2020

LPS antagonism reduces graft-versus-host disease and preserves graft-versus-leukemia activity after experimental bone marrow transplantation

1 reference

12 December 2020

Contrasting alloreactive CD4+ and CD8+ T cells: there's more to it than MHC restriction

1 reference

12 December 2020

The transplantation of hematopoietic stem cells after non-myeloablative conditioning: a cellular therapeutic approach to hematologic and genetic diseases

1 reference

12 December 2020

Morbidity and mortality with nonmyeloablative compared with myeloablative conditioning before hematopoietic cell transplantation from HLA-matched related donors

1 reference

12 December 2020

The biology of graft-versus-host reactions

1 reference

12 December 2020

Evaluation of HLA-haplotype disparate parental marrow grafts depleted of T lymphocytes by differential agglutination with a soybean lectin and E-rosette depletion for the treatment of severe combined immunodeficiency

1 reference

12 December 2020

Effects of treating marrow with a CD3-specific immunotoxin for prevention of acute graft-versus-host disease

1 reference

12 December 2020

Graft-v-host disease is associated with autoimmune-like thrombocytopenia

1 reference

12 December 2020

Pneumococcal conjugate vaccine provides early protective antibody responses in children after related and unrelated allogeneic hematopoietic stem cell transplantation

1 reference

12 December 2020

A retrospective analysis of therapy for acute graft-versus-host disease: secondary treatment

1 reference

12 December 2020

Chronic graft-versus-host disease and other late complications of bone marrow transplantation.

1 reference

12 December 2020

T-cell depletion of HLA-identical transplants in leukemia.

1 reference

12 December 2020

Late complications of allogeneic and autologous marrow transplantation

1 reference

12 December 2020

Cytokine dysregulation and acute graft-versus-host disease

1 reference

12 December 2020

Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2-incompatible transplanted SCID mice

1 reference

12 December 2020

Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients

1 reference

12 December 2020

Donor CD4-enriched cells of Th2 cytokine phenotype regulate graft-versus-host disease without impairing allogeneic engraftment in sublethally irradiated mice

1 reference

12 December 2020

The significance of HLA-DRB1 matching on clinical outcome after HLA-A, B, DR identical unrelated donor marrow transplantation

1 reference

12 December 2020

Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease

1 reference

12 December 2020

An experimental model of idiopathic pneumonia syndrome after bone marrow transplantation: I. The roles of minor H antigens and endotoxin

1 reference

12 December 2020

Adoptive immunotherapy with donor lymphocyte transfusions

1 reference

12 December 2020

Rapid engraftment without significant graft-versus-host disease after allogeneic transplantation of CD34+ selected cells from peripheral blood

1 reference

12 December 2020

Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: impact on blood progenitor cell transplantation

1 reference

12 December 2020

Total body irradiation and acute graft-versus-host disease: the role of gastrointestinal damage and inflammatory cytokines

1 reference

12 December 2020

Phase III study comparing methotrexate and tacrolimus (prograf, FK506) with methotrexate and cyclosporine for graft-versus-host disease prophylaxis after HLA-identical sibling bone marrow transplantation

1 reference

12 December 2020

NKT cell-dependent leukemia eradication following stem cell mobilization with potent G-CSF analogs.

1 reference

12 December 2020

10.1016/S0140-6736(09)60237-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19282026%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

PubMed publication ID

19282026

1 reference